Skip to main content

Table 1 Epidemiologic data of a typical HNSCC cohort, subdivided due to the insurance status. CUP: Cancer of unknown primary; C-/RT: Chemo-radiation

From: Mono-institutional retrospective cohort analysis of the insurance status dependent access to ENT-professionals and survival in head and neck squamous cell carcinoma

  General insurance Private insurance p-value
n 925 129  
Age (years)    0.06
 Median 60 62  
 Mean ± SD 60 ± 10 62 ± 11  
Sex, n (%)    0.19
 Male 731 (79) 108 (84)  
 Female 194 (21) 21 (16)  
Location, n (%)    0.52
 Sinonasal 32 (4) 3 (2)  
 Nasopharynx 14 (2) 5 (4)  
 Oropharynx 363 (39) 52 (40)  
 Hypopharynx 192 (21) 27 (21)  
 Larynx 180 (20) 27 (21)  
 Oral cavity 140 (15) 14 (11)  
 CUP 4 (< 1) 1 (1)  
T stage, n (%)    0.002
 T1/2 503 (54) 87 (67)  
 T3/4 418 (45) 41 (32)  
N stage, n (%)    0.86
 N0 366 (40) 50 (39)  
 N+ 559 (60) 79 (61)  
M stage, n (%)    0.76
 M0 886 (96) 127 (98)  
 M1 39 (4) 2 (2)  
Grading, n (%)    0.20
 G1 39 (4) 5 (4)  
 G2 452 (49) 53 (41)  
 G3 407 (44) 62 (48)  
 G4 27 (3) 5 (7)  
R status, n (%)    0.24
 R0 510 (83) 78 (80)  
 R1 52 (9) 6 (6)  
 R2 11 (2) 3 (3)  
 Rx 40 (7) 10 (10)  
UICC stage, n (%)    0.14
 UICC I 136 (15) 21 (16)  
 UICC II 117 (13) 17 (13)  
 UICC III 152 (16) 26 (20)  
 UICC IV 513 (56) 63 (49)  
Therapy, n (%)    0.31
 Surgery 164 (18) 23 (18)  
 Surgery + C/RT 433 (47) 69 (54)  
 pC/RT 328 (35) 37(29)